You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

July 31, 2024

Vietnam Issues First National Technical Regulation for Health Supplements

On July 18. 2024, Vietnam’s Ministry of Health issued Circular No. 12/2024/TT-BYT promulgating National Technical Regulation QCVN 20-1:2024/BYT on the limits of contaminants for health supplements (“Circular 12”). The new national technical regulation is the very first relating to health supplements, and is expected to have a great impact on the control of health supplement quality in Vietnam. Circular 12 will take effect on August 1, 2025.

Contents of Circular 12

The new circular prescribes limits of contaminants (heavy metals and microorganisms), testing samples and testing methods, management requirements, and responsibilities of entities manufacturing and trading in health supplements.

Supplemented alcohol products which are declared as health supplements are notably excluded from the scope of the regulation.

Transitional Provisions

Health supplements which (i) have been granted a declaration registration certificate, and (ii) are manufactured before August 1, 2025, are allowed to continue to be imported, traded, and circulated until the expiry date of the product, even if it is not aligned with Circular 12, except when there is food safety warning.

Declaration registration dossiers for health supplements submitted before August 1, 2025, will continue to be handled in accordance with the prevailing regulations at the time of submission.

From August 1, 2025, if a health supplement with a granted declaration registration certificate has a manufacturer’s standard that does not comply with Circular 12, the party manufacturing/trading in the product must adjust the product standard to conform to Circular 12 and notify the authority of this adjustment.

RELATED INSIGHTS​ 

May 5, 2014
While Vietnam represents a huge potential market for foreign investors in the pharmaceutical industry, the sector is heavily regulated and clear guidelines are not always available. To guide pharmaceutical clients in setting up a business, marketing products, and protecting their drugs from infringement in Vietnam, Tilleke & Gibbins’ commercial and patent experts have created an informational leaflet including the following contents:
April 9, 2014
The latest edition of Practical Law Company’s Life Sciences Multi-jurisdictional Guide has been published. The guide, presented to readers in a Q&A format, provides country-specific analysis of the current regulatory framework surrounding the life sciences industry. The Thailand chapter of this guide, written by Tilleke & Gibbins, looks at the critical legal issues surrounding such topics as national healthcare, manufacturing, marketing, pricing, intellectual property, and product liability law, among others. The chapter covers the following main subjects:
April 9, 2014
Practical Law Company recently published the latest edition of its Life Sciences Multi-jurisdictional Guide. The online guide, presented to readers in a Q&A format, provides country-specific analysis of the current regulatory framework surrounding the life sciences industry. This year’s guide has been divided into two sections, with the first section covering medicinal product regulations and product liability, and the second covering pharmaceutical IP and competition law.